{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:19:07Z","timestamp":1787008747789,"version":"build-2736575974"},"reference-count":16,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T00:00:00Z","timestamp":1700784000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,1,27]]},"DOI":"10.1093\/eurheartj\/ehad679","type":"journal-article","created":{"date-parts":[[2023,9,30]],"date-time":"2023-09-30T00:40:40Z","timestamp":1696034440000},"page":"306-308","source":"Crossref","is-referenced-by-count":7,"title":["On target inhibition of vascular smooth muscle cell phenotypic transition underpins TNF\u2013OXPHOS\u2013AP-1 as a promising avenue for anti-remodelling interventions in aortic dissection and rupture"],"prefix":"10.1093","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6722-8400","authenticated-orcid":false,"given":"Kapka","family":"Miteva","sequence":"first","affiliation":[{"name":"Division of Cardiology, Foundation for Medical Research, Department of Medicine, Faculty of Medicine, University of Geneva , Av. de la Roseraie 64 , 1211 Geneva, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,24]]},"reference":[{"key":"2024012712281788400_ehad679-B1","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1161\/CIRCULATIONAHA.112.000483","article-title":"Population-based study of incidence and outcome of acute aortic dissection and premorbid risk factor control: 10-year results from the Oxford vascular study","volume":"127","author":"Howard","year":"2013","journal-title":"Circulation"},{"key":"2024012712281788400_ehad679-B2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/cvr\/cvs135","article-title":"The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles","volume":"95","author":"Lacolley","year":"2012","journal-title":"Cardiovasc Res"},{"key":"2024012712281788400_ehad679-B3","doi-asserted-by":"crossref","first-page":"e13697","DOI":"10.1111\/eci.13697","article-title":"The role of vascular smooth muscle cells in the development of aortic aneurysms and dissections","volume":"52","author":"Rombouts","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"2024012712281788400_ehad679-B4","doi-asserted-by":"crossref","first-page":"4567","DOI":"10.1038\/s41467-018-06891-x","article-title":"Disease-relevant transcriptional signatures identified in individual smooth muscle cells from healthy mouse vessels","volume":"9","author":"Dobnikar","year":"2018","journal-title":"Nat Commun"},{"key":"2024012712281788400_ehad679-B5","doi-asserted-by":"crossref","first-page":"2693","DOI":"10.1161\/ATVBAHA.121.316600","article-title":"Six shades of vascular smooth muscle cells illuminated by KLF4 (Kruppel-like factor 4)","volume":"41","author":"Yap","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2024012712281788400_ehad679-B6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/eurheartj\/ehad534","article-title":"The activator protein-1 complex governs a vascular degenerative transcriptional programme in smooth muscle cells to trigger aortic dissection and rupture","volume":"45","author":"Luo","year":"2024","journal-title":"Eur Heart J"},{"key":"2024012712281788400_ehad679-B7","doi-asserted-by":"crossref","first-page":"E131","DOI":"10.1038\/ncb0502-e131","article-title":"AP-1 as a regulator of cell life and death","volume":"4","author":"Shaulian","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2024012712281788400_ehad679-B8","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1021\/jm5004733","article-title":"Small molecule inhibitors targeting activator protein 1 (AP-1)","volume":"57","author":"Ye","year":"2014","journal-title":"J Med Chem"},{"key":"2024012712281788400_ehad679-B9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1042\/CS20110234","article-title":"Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention study","volume":"122","author":"Meijer","year":"2012","journal-title":"Clin Sci (Lond)"},{"key":"2024012712281788400_ehad679-B10","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s12012-011-9135-x","article-title":"Toxicological insight from AP-1 silencing study on proliferation, migration, and dedifferentiation of rat vascular smooth muscle cell","volume":"12","author":"Zhang","year":"2012","journal-title":"Cardiovasc Toxicol"},{"key":"2024012712281788400_ehad679-B11","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/01.RES.0000094747.05021.62","article-title":"AP-1 is involved in UTP-induced osteopontin expression in arterial smooth muscle cells","volume":"93","author":"Renault","year":"2003","journal-title":"Circ Res"},{"key":"2024012712281788400_ehad679-B12","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/01.RES.0000023200.19316.D5","article-title":"Inhibitory effects of novel AP-1 decoy oligodeoxynucleotides on vascular smooth muscle cell proliferation in vitro and neointimal formation in vivo","volume":"90","author":"Ahn","year":"2002","journal-title":"Circ Res"},{"key":"2024012712281788400_ehad679-B13","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1021\/jm050550d","article-title":"Discovery of nonpeptidic small-molecule AP-1 inhibitors: lead hopping based on a three-dimensional pharmacophore model","volume":"49","author":"Tsuchida","year":"2006","journal-title":"J Med Chem"},{"key":"2024012712281788400_ehad679-B14","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/nbt1412","article-title":"Treatment of arthritis with a selective inhibitor of c-fos\/activator protein-1","volume":"26","author":"Aikawa","year":"2008","journal-title":"Nat Biotechnol"},{"key":"2024012712281788400_ehad679-B15","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1007\/s10529-012-1022-4","article-title":"T-5224, a selective inhibitor of c-Fos\/activator protein-1, attenuates lipopolysaccharide-induced liver injury in mice","volume":"34","author":"Izuta","year":"2012","journal-title":"Biotechnol Lett"},{"key":"2024012712281788400_ehad679-B16","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1186\/1471-2369-13-153","article-title":"The effects of a selective inhibitor of c-Fos\/activator protein-1 on endotoxin-induced acute kidney injury in mice","volume":"13","author":"Miyazaki","year":"2012","journal-title":"BMC Nephrol"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/4\/306\/56432896\/ehad679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/45\/4\/306\/56432896\/ehad679.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,29]],"date-time":"2024-10-29T14:05:23Z","timestamp":1730210723000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/45\/4\/306\/7448533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,24]]},"references-count":16,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,11,24]]},"published-print":{"date-parts":[[2024,1,27]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehad679","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,1,21]]},"published":{"date-parts":[[2023,11,24]]}}}